GleamWall
中文EN

OMDA Omada Health, Inc.

Services-Health Services · Nasdaq · SEC CIK 1611115 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY43.3%
TTM net income YoY153.6%
TTM EPS YoY124.5%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin70.7%
Operating margin2.1%
Net margin4.2%
FCF margin8.5%
EBITDA margin3.9%

Returns

ROE5.7%
ROA4.4%
ROIC (approx.)28.2%
Asset turnover1.05x

Leverage & solvency

Liabilities / assets21.6%
Debt / equity0.00x
Current ratio4.18x
Interest coverage22.37x

Cash quality & payout

Operating cash flow / net income2.04x
Accruals ratio-4.6%
Payout ratio—
Capex / revenue0.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$91.31M$87.83M$78.05M$75.85M$68.03M$61.37M$54.96M$47.98M
Cost of revenue$22.02M$24.05M$29.36M$22.18M$22.96M$21.07M$23.06M$15.85M
Gross profit$69.28M$63.79M$48.69M$53.66M$45.07M$40.31M$31.90M$32.13M
R&D expense$15.27M$14.62M$12.70M$11.55M$10.30M$10.02M$8.81M$9.19M
SG&A expense$20.08M$15.72M$13.99M$14.22M$14.34M$12.31M$11.32M$11.95M
Operating income$4.82M$3.55M-$4.78M$3.28M-$2.51M-$4.34M-$8.40M-$7.10M
Interest expense$262,000$14,000$18,000$13,000$353,000$1.09M$1.07M$1.10M
Pretax income$6.55M$5.29M-$2.97M$5.16M-$3.18M-$5.31M-$9.45M-$8.25M
Income tax$0$0$0$0$0$0$0$0
Net income$6.55M$5.29M-$2.97M$5.16M-$3.18M-$5.31M-$9.45M-$8.25M
EBITDA$6.50M$5.13M-$3.27M$4.73M-$1.15M-$2.99M-$7.06M-$5.82M
EPS (basic)0.110.09-0.05—-0.06-0.24-1.15—
EPS (diluted)0.100.08-0.05—-0.06-0.24-1.15—
Weighted avg. shares (diluted)67.12M63.95M58.92M—57.66M21.97M8.24M—
Balance sheet
Cash & equivalents$243.15M$221.71M$211.76M$222.04M$198.63M$223.15M$59.40M$76.39M
Receivables$48.19M$56.57M$39.98M$34.59M$41.45M$33.29M—$23.42M
Inventory$4.88M$4.12M$3.83M$4.49M$3.15M$3.47M—$3.30M
Current assets$315.06M$294.91M$269.43M$272.93M$254.90M$271.11M—$113.06M
PP&E, net$9.74M$9.10M$8.46M$7.94M$7.54M$6.48M—$5.62M
Goodwill$13.24M$13.24M$13.24M$13.24M$13.24M$13.24M—$13.24M
Intangibles$1.10M$1.54M$1.98M$2.41M$2.85M$3.29M—$4.26M
Total assets$348.54M$328.22M$302.80M$305.41M$287.47M$302.97M—$150.89M
Current liabilities$75.38M$75.48M$68.68M$75.73M$70.12M$57.99M—$53.95M
Long-term debt———$0$0$29.97M—$29.77M
Total debt———$0$0$29.97M—$29.77M
Total liabilities$75.38M$75.48M$68.68M$75.73M$70.12M$88.76M—$86.26M
Shareholders' equity$273.16M$252.74M$234.12M$229.68M$217.35M$214.21M-$390.05M-$384.40M
Net debt———-$222.04M-$198.63M-$193.18M—-$46.62M
Shares outstanding62.00M60.61M59.24M58.43M57.89M57.32M—8.16M
Cash flow statement
Operating cash flow$15.14M$4.01M-$11.83M$21.38M$10.13M$2.86M-$16.12M-$6.49M
Capital expenditure$118,000$146,000$78,000$199,000$537,000$271,000$315,000$184,000
Free cash flow$15.02M$3.86M-$11.91M$21.18M$9.60M$2.59M-$16.43M-$6.67M
Investing cash flow-$1.63M-$1.66M-$1.56M-$1.35M-$1.99M-$1.25M-$1.25M-$969,000
Financing cash flow$7.93M$7.60M$3.12M$3.38M-$32.66M$162.14M$372,000$113,000
Depreciation & amortization$1.68M$1.58M$1.51M$1.45M$1.36M$1.35M$1.33M$1.28M
Stock-based compensation$5.85M$5.63M$4.21M$3.75M$3.54M$2.83M$2.84M$2.31M

Free plan shows the latest 8 periods; Pro shows all 11 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.